Noncoding RNA, friend or foe for nephrolithiasis?

Area of Science:

• Urology
• Molecular Biology
• Genetics

Background:

• Nephrolithiasis (kidney stones) is a prevalent urological disease with high recurrence rates, causing significant morbidity and economic burden.
• The exact mechanisms of kidney stone formation are not fully understood, limiting therapeutic advancements.
• Noncoding RNAs (ncRNAs) are crucial regulators of gene expression and disease progression, emerging as potential diagnostic and therapeutic targets.

Purpose of the Study:

• To review the expression profiles, biological functions, and clinical significance of ncRNAs involved in nephrolithiasis.
• To enhance the understanding of ncRNAs as potential diagnostic and therapeutic targets for kidney stone disease.

Main Methods:

• Literature review summarizing current research on ncRNAs in nephrolithiasis.
• Analysis of ncRNA expression patterns and their functional roles in stone formation.
• Evaluation of the clinical relevance and potential applications of nephrolithiasis-associated ncRNAs.

Main Results:

• ncRNAs have been identified to influence key processes in stone formation, including ion transport, oxidative stress, inflammation, osteoblastic transformation, autophagy, and pyroptosis.
• Specific ncRNAs show altered expression profiles in nephrolithiasis patients.
• These ncRNAs represent novel molecular players in the pathogenesis of kidney stones.

Conclusions:

• ncRNAs offer new insights into the complex pathogenesis of nephrolithiasis.
• ncRNAs hold significant promise as biomarkers for diagnosis and as therapeutic targets for kidney stone management.
• Further research into ncRNA mechanisms is warranted to fully exploit their clinical potential.